Loebsack Praises Committee Passage of Bill to Speed Approval of New Medical CuresWritten by Theresa Rose on May 21, 2015
21st Century Cures Act contains $10 billion for NIH research
Washington, D.C. – Congressman Dave Loebsack released the following statement today after the House Energy and Commerce Committee, of which he is a member, passed legislation that will streamline the Food and Drug Administration’s (FDA) approval process of new medical cures and drugs. It includes $10 billion for the National Institutes of Health (NIH) Innovation Fund. The 21st Century Cures Act is paid for and passed the committee by a unanimous 51-0 vote.
“The 21st Century Cures Act is a truly bipartisan piece of legislation that will have a profound effect on our medical community as well as the people who are suffering from many different diseases, including cancer and type 2 diabetes. I’m particularly excited about the NIH Innovation fund. I’m proud to represent the University of Iowa, an institution that is at the forefront of groundbreaking medical research. The five year, ten billion dollar NIH Innovation fund will at long last provide a boost to funding for medical research. The 21st Century Cures Act is proof that we can accomplish great things when we put our partisan differences aside and come together around a common goal. I’m pleased to be a part of this bipartisan effort.”
The 21st Century Cures Act is nonpartisan legislation that is the product of more than a year of listening to patients, researchers, caregivers, and innovators. It seeks to modernize the nation’s health care innovation ecosystem, encourage greater biomedical innovation, and help get more cures and treatments to patients faster.